Bolt Biotherapeutics Inc. (BOLT)
NASDAQ
Bolt Biotherapeutics Inc. EBITDA 2020–2025
Bolt Biotherapeutics Inc. annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Bolt Biotherapeutics Inc. ebitda for the quarter ending March 31, 2026 was -7.4 M, a 36.86% decrease year-over-year.
- Bolt Biotherapeutics Inc. ebitda for the twelve months ending March 31, 2026 was -53.7 M.
- Bolt Biotherapeutics Inc. annual ebitda for 2025 was -34.8 M, a 51.14% decrease from 2024.
- Bolt Biotherapeutics Inc. annual ebitda for 2024 was -71.3 M, a 4.14% decrease from 2023.
- Bolt Biotherapeutics Inc. annual ebitda for 2023 was -74.3 M, a 16.14% decrease from 2022.
- Bolt Biotherapeutics Inc. annual ebitda for 2022 was -88.7 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bolt Biotherapeutics Inc. EBITDA — FAQ
Bolt Biotherapeutics Inc. (BOLT) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BOLT's ebitda history?
The chart and table above show Bolt Biotherapeutics Inc.'s ebitda by year and by quarter, including the growth rate.